Krystal Biotech Inc Earnings

Krystal Biotech Inc’s revenue jumped 16.65% since last year same period to $97.8Mn in the Q3 2025. On a quarterly growth basis, Krystal Biotech Inc has generated 1.83% jump in its revenue since last 3-months.

Krystal Biotech Inc’s net profit jumped 192% since last year same period to $79.36Mn in the Q3 2025. On a quarterly growth basis, Krystal Biotech Inc has generated 107.04% jump in its net profits since last 3-months.

Krystal Biotech Inc’s net profit margin jumped 150.32% since last year same period to 81.15% in the Q3 2025. On a quarterly growth basis, Krystal Biotech Inc has generated 103.32% jump in its net profit margins since last 3-months.

Krystal Biotech Inc’s earning per share (EPS) estimates for the current quarter stand at 1.12 - a -8.2% fall from last quarter’s estimates.

Krystal Biotech Inc’s earning per share (EPS) estimates for the current year stand at 1.12.

Krystal Biotech Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Krystal Biotech Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.